Literature DB >> 27362238

Awareness, Treatment and Control of Pre-hypertension and Hypertension among Adults in Iran.

Alireza Esteghamati1, Koorosh Etemad2, Jalil Koohpayehzadeh2, Mehrshad Abbasi3, Alipasha Meysamie4, Elias Khajeh3, Fereshteh Asgari2, Sina Noshad3, Ali Rafei2, Mostafa Mousavizadeh3, Mohamad Reza Neishaboury3, Mohsen Afarideh3, Manouchehr Nakhjavani3.   

Abstract

BACKGROUND: Hypertension is a major risk factor for non-communicable diseases. Yet, Nation-wide prevalence and trend reports in developing countries are sparsely available.
METHODS: Data from three cycles of Survey of Risk Factors of Non-communicable Diseases (SuRFNCD) 2005 - 2011 were aggregated. In 2011, 8218 adults aged 25 - 70 years were enrolled. For trend analysis 68850, 4184, and 7416 adults aged 25 - 64 years were included from 2005, 2007, and 2011 surveys, respectively. Hypertension was defined as systolic blood pressure (SBP) ≥ 140 mmHg, diastolic blood pressure (DBP) ≥ 90 mmHg, or receiving anti-hypertensive medication. Pre-hypertension was defined as SBP between 120 - 139 or DBP between 80 - 89 mmHg. The status of awareness, non-pharmacologic treatment (management), pharmacologic treatment, and control (SBP < 140 mmHg, and DBP < 90 mmHg) among hypertensive individuals were also determined.
RESULTS: 25.6% (95%CI: 23.5 - 27.5) of the adults aged 25 - 70 years had hypertension and 39.8% (95%CI: 37.8 - 41.9) had pre-hypertension. The prevalence of hypertension was greater among older adults (P < 0.001), women (P = 0.013), and urban-dwellers (P = 0.027). In 2005 - 2011, the proportion of adults with hypertension (25.7% to 24.1%) and pre-hypertension (45.5% to 40.4%) significantly decreased. In 2011, rates for awareness, management, treatment, and control among hypertensives were 43.2% (95%CI: 40.0 - 46.4), 40.3% (95%CI: 37.0 - 43.6), 34.8% (95%CI: 31.5 - 38.2), and 38.6% (95%CI: 33.1 - 44.2), respectively. Over time, status of awareness, management, treatment and control was significantly improved and was more salient among men (P < 0.05 for all analyses).
CONCLUSIONS: The prevalence of hypertension and pre-hypertension is gradually declining. Despite improvements in awareness, management, treatment and control, these decline rates are still low and initiative strategies need to be implemented to further improve the current status.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27362238     DOI: 0161907/AIM.003

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  21 in total

1.  Estimation of Generalized Impact Fraction and Population Attributable Fraction of Hypertension Based on JNC-IV and 2017 ACC/AHA Guidelines for Cardiovascular Diseases Using Parametric G-Formula: Tehran Lipid and Glucose Study (TLGS).

Authors:  Mohammad Saatchi; Mohammad Ali Mansournia; Davood Khalili; Rajabali Daroudi; Kamran Yazdani
Journal:  Risk Manag Healthc Policy       Date:  2020-08-05

2.  Prevalence, Awareness, Treatment, and Control of Hypertension among Adult Residents of Tehran: The Tehran Cohort Study.

Authors:  Alireza Oraii; Akbar Shafiee; Arash Jalali; Farshid Alaeddini; Soheil Saadat; Saeed Sadeghian; Hamidreza Poorhosseini; Mohamamdali Boroumand; Abbasali Karimi; Oscar H Franco
Journal:  Glob Heart       Date:  2022-05-11

3.  Letter to the Editor re "Hypertension and Pre-Hypertension Among Iranian Adults Population: a Meta-Analysis of Prevalence, Awareness, Treatment, and Control" by Afsargharehbagh et al. (2019) Published in Current Hypertension Reports.

Authors:  Farid Najafi; Fatemeh Rajati
Journal:  Curr Hypertens Rep       Date:  2019-07-10       Impact factor: 5.369

4.  Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016).

Authors:  Alireza Esteghamati; Bagher Larijani; Mohammad Haji Aghajani; Fatemeh Ghaemi; Jamshid Kermanchi; Ali Shahrami; Mohammad Saadat; Ensieh Nasli Esfahani; Morsaleh Ganji; Sina Noshad; Elias Khajeh; Alireza Ghajar; Behnam Heidari; Mohsen Afarideh; Jeffrey I Mechanick; Faramarz Ismail-Beigi
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

5.  Healthy lifestyle behaviors and control of hypertension among adult hypertensive patients.

Authors:  Samaneh Akbarpour; Davood Khalili; Hojjat Zeraati; Mohammad Ali Mansournia; Azra Ramezankhani; Akbar Fotouhi
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379

6.  Evaluation of cardiovascular risk factors in women referring to health centers in Tabriz, Iran, 2017.

Authors:  Roghayeh Molani Gol; Maryam Rafraf; Mohammad Asghari Jafarabadi
Journal:  Health Promot Perspect       Date:  2018-10-27

Review 7.  Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS).

Authors:  Hengameh Abdi; Atieh Amouzegar; Maryam Tohidi; Fereidoun Azizi; Farzad Hadaegh
Journal:  Int J Endocrinol Metab       Date:  2018-10-20

8.  Spousal metabolic risk factors and incident hypertension: A longitudinal cohort study in Iran.

Authors:  Azra Ramezankhani; Kamran Guity; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-31       Impact factor: 3.738

9.  Awareness, treatment, and control of hypertension and related factors in adult Iranian population.

Authors:  Mohsen Mirzaei; Masoud Mirzaei; Behnam Bagheri; Ali Dehghani
Journal:  BMC Public Health       Date:  2020-05-12       Impact factor: 3.295

10.  Changes in the prevalence of measures associated with hypertension among Iranian adults according to classification by ACC/AHA guideline 2017.

Authors:  Mohsen Mirzaei; Masoud Mirzaei; Mojtaba Mirzaei; Behnam Bagheri
Journal:  BMC Cardiovasc Disord       Date:  2020-08-14       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.